title: Anti-Leishmania titers and positive skin tests in patients cured of kala-azar.
abstract: Visceral leishmaniasis (VL), also known as kala-azar, is an important public health problem. If not treated, virtually all clinically symptomatic patients die within months. The diagnosis is based on the Montenegro skin test (MST) and anti-Leishmania titers. Nevertheless, the time required for cured individuals living in a leishmaniasis-endemic area to present a positive skin test and negative anti-Leishmania serology is known. To determine the cellular and humoral immune response profile in relation to different times post-VL cure, a cross-sectional study was conducted on subjects from a kala-azar endemic area in Paço do Lumiar, MA, Brazil, on the basis of 1995-2005 notifications reported by the National Health Foundation/Regional Coordination of Maranhão. We visited cured individuals with a history of VL within the last 10 years. Seventy-four subjects (30 females) ranging in age from 1 to 44 years were included, all of them symptom free at the time of the study. A cellular immune response was observed in 73 (98.6%) subjects, whereas no significant antibody titers were detected by indirect immunofluorescence (IIF) in the sera of 69 (93.2%) cases. Ten years post-cure, 39 (52%) subjects had a positive MST and negative IIF reaction, while in one subject the skin and anti-Leishmania serology tests were negative. Two other subjects were positive in both tests 1 year after cure. These data suggest that a cellular immune response may still be present in subjects cured of VL regardless of post-cure time, and that the parasite persists in the host after clinical cure of the disease. This would explain the persistence of significant Leishmania sp antibody titers in some subjects after treatment.
authors.affiliation: Departamento de Patologia, Universidade Federal do Maranhão, São Luís, MA, Brasil. gracaviana@globo.com
authors.forename: G M C
authors.initials: GM
authors.lastname: Viana
authors.forename: M D S B
authors.initials: MD
authors.lastname: Nascimento
authors.forename: J A
authors.initials: JA
authors.lastname: Diniz Neto
authors.forename: E M F
authors.initials: EM
authors.lastname: Rabelo
authors.forename: J R
authors.initials: JR
authors.lastname: Binda Júnior
authors.forename: O M
authors.initials: OM
authors.lastname: Santos Júnior
authors.forename: A C
authors.initials: AC
authors.lastname: Santos
authors.forename: C S
authors.initials: CS
authors.lastname: Galvão
authors.forename: R S
authors.initials: RS
authors.lastname: Guimarães
mesh_terms: D000293:Adolescent; D000328:Adult; D000913:Antibodies, Protozoan / Q000097:blood* / Q000276:immunology; D002648:Child; D002675:Child, Preschool; D003430:Cross-Sectional Studies; D005260:Female; D019084:Fluorescent Antibody Technique, Indirect; D006801:Humans; D007111:Immunity, Cellular / Q000276:immunology*; D007223:Infant; D007428:Intradermal Tests; D007898:Leishmaniasis, Visceral / Q000276:immunology*; D008297:Male; D055815:Young Adult
chemical_list: D000913:Antibodies, Protozoan